Biosenic (XPAR:BIOS) Long-Term Debt: €23.23 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biosenic Long-Term Debt?

Biosenic XPAR:BIOS 9 Long-Term Debt is €23.23 Mil as of Dec. 2024. GuruFocus rates XPAR:BIOS with a GF Score™ of 9/100. The stock has 5 warning signs investors should review.

Biosenic's Long-Term Debt for the quarter that ended in Dec. 2024 was €23.23 Mil.

Biosenic's quarterly Long-Term Debt increased from Dec. 2023 (€15.57 Mil) to Jun. 2024 (€22.61 Mil) and increased from Jun. 2024 (€22.61 Mil) to Dec. 2024 (€23.23 Mil).

Biosenic's annual Long-Term Debt increased from Dec. 2022 (€14.78 Mil) to Dec. 2023 (€15.57 Mil) and increased from Dec. 2023 (€15.57 Mil) to Dec. 2024 (€23.23 Mil).

Biosenic  (XPAR:BIOS) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Biosenic Long-Term Debt Related Terms

Biosenic Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Biosenic's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosenic Long-Term Debt Chart

Biosenic Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.67 2.27 14.78 15.57 23.23

Biosenic Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.78 0.00 15.57 22.61 23.23
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €23.23 Mil mean?
Biosenic (XPAR:BIOS) has a Long-Term Debt of €23.23 Mil as of Dec. 2024.
Is Biosenic's Long-Term Debt too high?
Biosenic's current Long-Term Debt is €23.23 Mil. Overall, Biosenic has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Biosenic's Long-Term Debt compare to VRTX and REGN?
Biosenic's Long-Term Debt of €23.23 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Biosenic's current Long-Term Debt is €23.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosenic stock overvalued right now?
Biosenic (XPAR:BIOS) has a current Long-Term Debt of €23.23 Mil. The current Long-Term Debt is €23.23 Mil. Biosenic's overall GF Score™ is 9/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Biosenic (XPAR:BIOS), the current Long-Term Debt is €23.23 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biosenic Business Description

Address Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, BEL, 1435
Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.